Neuromuscular Symptoms Unit, National Institute of Nursing Research (NIH), United States.
Mark O Hatfield Clinical Center, National Institutes of Health (NIH), United States.
J Neuromuscul Dis. 2019;6(1):133-141. doi: 10.3233/JND-180335.
RYR1-related disorders (RYR1-RD), are a spectrum of genetic neuromuscular disorders. Affected individuals frequently experience fatigue yet appropriate tools to assess RYR1-RD-associated fatigue remain underdeveloped.
This study assessed the reliability and validity of two self-report questionnaires, the multidimensional fatigue inventory (MFI-20) and adult/pediatric functional assessment of chronic illness-fatigue (FACIT-F/Peds-FACIT-F) as potential fatigue measures in RYR1-RD affected individuals.
Participants (n = 37) were enrolled in an RYR1-RD combined natural history study and clinical trial. At baseline, participants completed fatigue questionnaires, six-minute walk test (6MWT), cardiopulmonary exercise test (CPET) and saliva collection for fatigue biomarker index (FBI) quantification.
All questionnaires exhibited good test-retest reliability (n = 18, ICC > 0.80). MFI-20 (n = 37), and FACIT-F (n = 28) also showed good internal consistency (Cronbach's α> 0.80). All MFI-20 subscales, except mental fatigue, and FACIT-F demonstrated evidence of criterion validity when correlated against percent predicted 6MWT distance (MFI-20 n = 37; r = -0.34 to -0.47, all p < 0.05, mental fatigue, r = -0.16, p = 0.35; FACIT-F n = 28, r = 0.41, p = 0.03). This was not the case for percent predicted VO2 peak (all p > 0.05). FBI correlated with MFI-20 general fatigue dimension only (r = -0.35, p = 0.03). Comparison of standardized questionnaire scores revealed that RYR1-RD affected individuals experience significantly greater fatigue than the general population.
MFI-20 and FACIT-F are valid and reliable tools for assessing RYR1-RD-associated fatigue, a symptom centrally implicated in this rare disorder.
RYR1 相关疾病(RYR1-RD)是一组遗传性神经肌肉疾病。受影响的个体经常感到疲劳,但评估 RYR1-RD 相关疲劳的适当工具仍未得到充分发展。
本研究评估了多维疲劳量表(MFI-20)和成人/儿科慢性疾病疲劳评估量表(FACIT-F/Peds-FACIT-F)这两个自我报告问卷作为 RYR1-RD 受影响个体潜在疲劳测量工具的可靠性和有效性。
参与者(n=37)被招募到 RYR1-RD 联合自然史研究和临床试验中。在基线时,参与者完成了疲劳问卷、六分钟步行测试(6MWT)、心肺运动测试(CPET)和唾液采集以进行疲劳生物标志物指数(FBI)定量。
所有问卷均表现出良好的重测信度(n=18,ICC>0.80)。MFI-20(n=37)和 FACIT-F(n=28)也表现出良好的内部一致性(Cronbach's α>0.80)。当与预测 6MWT 距离的百分比相关时,所有 MFI-20 子量表(除了精神疲劳)和 FACIT-F 都显示出了标准有效性的证据(MFI-20 n=37;r=-0.34 至-0.47,所有 p<0.05,精神疲劳,r=-0.16,p=0.35;FACIT-F n=28,r=0.41,p=0.03)。这与预测 VO2 峰值的百分比无关(所有 p>0.05)。FBI 仅与 MFI-20 一般疲劳维度相关(r=-0.35,p=0.03)。标准化问卷评分的比较表明,RYR1-RD 受影响个体经历的疲劳明显大于一般人群。
MFI-20 和 FACIT-F 是评估 RYR1-RD 相关疲劳的有效且可靠的工具,而疲劳是这种罕见疾病的核心症状。